Michelle Kang Kim, MD, PhD, the chair of the Department of Gastroenterology, Hepatology and Nutrition at Cleveland Clinic, in Cleveland, talks about breaking the glass ceiling, sharing insights into the process of becoming a leader. Dr. Kim told Gastroenterology & Endoscopy News at Digestive Disease Week 2023 that the path to becoming a chair is not always intuitive.- GEN Staff Read More
Author: Abhay Panchal
DUBLIN — A swallowable gastric balloon (Allurion Balloon, formerly known as Elipse) combined with daily subcutaneous injections of the glucagon-like peptide 1 (GLP-1) agonist liraglutide (Saxenda, Novo Nordisk), leads to a significant average total body weight loss of 19% (18 kg or 40 lb) after around 4 months in people with obesity. “The combination therapy [balloon and liraglutide] resulted in an additional weight loss compared to the two single treatments,” said Roberta Ienca, MD, from the Clinica Nuova Villa Claudia, Rome, Italy, who presented the findings at this year’s European Congress on Obesity (ECO). “Despite both the balloon and liraglutide…
Gastro Health, a leading gastroenterology group, plans to utilize this simplified blood collection method when recommending the inFoods® IBS to their patients Biomerica also announced that inFoods® IBS clinical trial data was presented at the DDW conference May 8th.The data showed that the inFoods® IBS treatment diet significantly improved several key IBS symptoms including Abdominal Pain Intensity (API) inFoods IBS showed improvement in API similar to, and in some cases better than, current IBS drugs in the market NEWPORT BEACH, Calif., May 18, 2023 (GLOBE NEWSWIRE) — Biomerica Inc. (NASDAQ: BMRA), a global biomedical company leading the way in innovative…
There are a number of utilities for artificial intelligence (AI) in medicine that could have a drastic impact on the field? One such method is for polyp detection following a colonoscopy for colorectal cancer screenings. In a presentation during the 2023 Digestive Disease Week (DDW) in Chicago, Aasma Shaukat, MD, MPH, Director of Research Outcomes, Division of Gastroenterology and Hepatology, NYU Langone, discussed how doctors can better use new technologies like AI for cancer screenings. “Artificial intelligence is here to stay,” Shaukat said in an interview with HCPLive®. “It will make our job in delivering health care and promoting and…
The American College of Gastroenterology recently released an updated clinical guideline on the diagnosis and management of celiac disease (Am J Gastroenterol 2023;118[1]:59-76). GEN‘s Sarah Tilyou spoke with lead author Alberto Rubio Tapia, MD, the director of the celiac disease program at Cleveland Clinic, in Ohio, about the impetus for the guideline and what it means to GI practice. Read More
As we have previously noted, private equity (PE) firms have been increasingly drawn to the health care sector as a profitable investment opportunity. PE is a type of investment that involves pooling funds from investors in order to acquire companies with a goal of improving their financial performance to then sell them for a profit. One recent area of interest for PE firms has been gastroenterology, the branch of medicine that focuses on the digestive system and its disorders. Private equity firms are attracted to this field due to the steady demand for gastrointestinal (GI) services, which are required by…
Gastroenterology is a service line with unlimited potential for growth. The expanding patient need for services, combined with advancements that allow more procedures to be performed in outpatient settings, have made gastroenterology an attractive target for investors. Patients utilize gastroenterology services throughout their lifetimes. Gastroenterologists treat a wide variety of conditions impacting the digestive system, which includes the stomach, intestines, gallbladder, pancreas, and liver. Clinicians care for patients experiencing everything from abdominal pain and heartburn to nonalcoholic fatty liver disease and cancers. The stats show that chronic digestive issues keep providers busy: Up to 100 million Americans have some form…
Key takeaways: Upadacitinib is the first approved oral product to treat moderately to severely active Crohn’s disease. Expanded upadacitinib use is approved for patients who are refractory to treatment with one or more TNF inhibitors. The FDA has approved AbbVie’s Rinvoq as a once-day pill intended for the treatment of adult patients with moderate to severe Crohn’s disease who are intolerant, or have had an inadequate response, to one or more TNF inhibitors. Read More
New York tops the list of states that are most in-demand for permanent placement opportunities for gastroenterologists, according to a post from physician search and employment firm Merritt Hawkins. Ten most in-demand states for permanent GI placement: New York Ohio Texas California Kentucky read More
Bringing in a physician partner has many advantages: A partner may help your practice grow and become more successful; partners allow you to share the workload and to combine skills with another provider; and you can enrich your practice by having a solid teammate. However, business partners can become your greatest asset or worst liability. Deciding whether or not to share your practice with someone else may be one of the most important business decisions you ever make. Deciding who you go into business with can be just as important. Read More